[July 23, 2014] |
 |
PHT Corporation Reports Record Breaking 2nd Quarter as Pharma Industry Champions Patient-Driven eData Systems in Clinical Research
BOSTON & GENEVA --(Business Wire)--
PHT
Corporation is experiencing exponential growth in 2014 with a 124%
increase in demand for products and services in the second quarter over
the same period in 2013. PHT is the leading provider of technologies
used to collect patient-driven
eData for clinical research. Sponsors and CROs use PHT products and
services to deploy clinical outcome assessments on the web, smartphones
and tablets.
The PHT eCOA
System was chosen by 14 pharmaceutical and biotechnology companies
including 3 new clients to collect compliant, patient-driven eData for
25+ clinical research programs in over 7 therapeutic areas. Sales were
both direct to customer and through CRO partnerships. Top therapeutic
areas included CNS, endocrinology, respiratory and oncology.
PHT President and CEO Philip Lee said, "PHT has been actively preparing
for this growth in new business by increasing our capacity, tools and
infrastructure. The investment in the PHT Product Suite to use the
latest devices including the Nexus 5, Dell (News - Alert) Venue with embedded 3G and 4G
connectivity, and support for the BYOD models is paying dividends
through added system flexibility and ease of use by patients, sites and
sponsors."
The FDA's growing focus on patient reported outcomes (PROs) including
symptom data in therapies like oncology was illustrated by the recent
rejection of a new drug application for a malignant melanoma drug due to
insufficient symptom-level data. http://www.pharmamedtechbi.com/publications/rpm-report/first-take/2014/4/provectus-breakthrough-denial-is-symptom-of-a-different-breakthrough-at-fda
Additional PHT Q2 highlights included:
PHT Vice President of Marketing and Product Management Sheila Rocchio,
MBA, commented, "The PHT Product Suite helps clinical trial sponsors
support more patient-centric trials. The Medication Module is helping
sponsors and patients more accurately track and manage rescue and
concomitant medication in real time, resulting in a better trial
experience for both patients and sites." Sheila discusses how PHT's
patient suite promotes patient healthcare, and how an app for every
trial enables patient-centric research: http://bit.ly/PatientSuite
About PHT Corporation
PHT Corporation is the eClinical innovator leading the adoption of
patient-driven mobile apps for better clinical research. The PHT
electronic clinical outcome assessment (eCOA) system collects and
reports secure real-time patient data from the latest mobile devices.
PHT scientific, regulatory and technological expertise combined with
quality outcomes data enables clients to make research decisions with
confidence. Sponsors and CROs have leveraged the PHT Patient Suite in
650+ trials resulting in 16+ regulatory approvals. Visit phtcorp.com.
Join the PRO
& eCOA Congress LinkedIn Community. Follow PHT on LinkedIn,
Facebook,
Twitter,
Google+
and YouTube.

[ Back To TMCnet.com's Homepage ]
|